Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pan-cancer analyses confirmed the cuproptosis-related gene FDX1 as an immunotherapy predictor and prognostic biomarker

5 Aug 2022

Abstract excerpt

Background: The latest research identified cuproptosis as an entirely new mechanism of cell death. However, as a key regulator in copper-induced cell death, the prognostic and immunotherapeutic value of FDX1 in pan-cancer remains unclear. Methods: Data from the UCSC Xena, GEPIA, and CPTAC were analyzed to conduct an inquiry into the overall differential expression of FDX1 across multiple cancer types. The...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related molecular mechanisms research
Share to Ferroptosis and cancer prognosis
Share to RNA modifications and cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35991547
DOI: 10.3389/fgene.2022.923737

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pan-cancer analyses confirmed the cuproptosis-related gene FDX1 as an immunotherapy predictor and prognostic biomarkerPMID 35991547Read ↗

Prognostic and immunological role of cuproptosis-related protein FDX1 in pan-cancerSemantic proximity Read ↗

Pan-cancer integrated bioinformatics analysis reveals cuproptosis related gene FDX1 is a potential prognostic and immunotherapeutic biomarker for lower-grade gliomasSemantic proximity Read ↗

Regulation, genomics, and clinical characteristics of cuproptosis regulators in pan-cancerSemantic proximity Read ↗

Pan-cancer analysis of potential biological function and prognostic value of copper homeostasis related gene ferredoxin-1Semantic proximity Read ↗

The potential role of cuproptosis-related genes for therapy and immunoregulation in pan-cancerSemantic proximity Read ↗

Identifying Cuproptosis-Related Hub Genes and Their Clinical Significance in TumorsSemantic proximity Read ↗

Pan-cancer patterns of cuproptosis markers reveal biologically and clinically relevant cancer subtypesSemantic proximity Read ↗

A Pan-Cancer Analysis of prognosis and immunity of cuproptosis-related gene FDX1Semantic proximity Read ↗

Characterization of the functional effects of ferredoxin 1 as a cuproptosis biomarker in cancerSemantic proximity Read ↗

Pan-cancer profiles of cuproptosis gene set regarding the potential values of diagnosis, prognosis, immune therapy, and drug therapy predictionSemantic proximity Read ↗

Comprehensive investigation into cuproptosis in the characterization of clinical features, molecular characteristics, and immune situations of clear cell renal cell carcinomaSemantic proximity Read ↗

Molecular Function Validation and Prognostic Value Analysis of the Cuproptosis-Related Gene Ferredoxin 1 in Colon CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.